Epigenetic inactivation of the hMLH1 gene in progression of gliomas

Diagnostic Molecular Pathology

Volumn 16, Issue 2, 2007, Pages 104-107

  Gömöri, Éva ^a   Pál, József ^a   Mészáros, István ^a   Dóczi, Tamás ^a   Matolcsy, András ^b  

^a UNIVERSITY OF PÉCS   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Glioma; hMLH1 gene; Hypermethylation; Tumor progression

Indexed keywords

PROTEIN MLH1; DNA; MLH1 PROTEIN, HUMAN; NUCLEAR PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOPSY; CLINICAL ARTICLE; DISEASE COURSE; DNA REPAIR; EPIGENETICS; EVOLUTION; FEMALE; GENE INACTIVATION; GENE STRUCTURE; GLIOMA; HUMAN; HUMAN TISSUE; MALE; METHYLATION; MISMATCH REPAIR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SINGLE STRAND CONFORMATION POLYMORPHISM; STRUCTURE ANALYSIS; TUMOR GROWTH; TUMOR RECURRENCE; BRAIN TUMOR; CHILD; DISEASE FREE SURVIVAL; DNA METHYLATION; GENE SILENCING; GENETIC EPIGENESIS; GENETICS; METABOLISM; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; SURVIVAL RATE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CHILD; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DNA METHYLATION; DNA, NEOPLASM; EPIGENESIS, GENETIC; FEMALE; GENE SILENCING; GLIOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SURVIVAL RATE;

EID: 34347382413     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/PDM.0b013e318033f140     Document Type: Article

References (25)

1. Rostomily RC, Spence AM, Duong D, et al. Multimodality management of recurrent adult malignant gliomas: results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery. Neurosurgery. 1994;35:378-388.
2. Ammirati M, Galicich JH, Arbit E, et al. Reoperation in the treatment of recurrent intracranial malignant gliomas. Neurosurgery. 1987;21:607-614.
3. Gömöri É, Nagy M, Mészéros I, et al. Microsatellite analysis of primary and recurrent glial tumors suggest different modality of clonal evolution of the tumor cells. J Neuropath Exp Neurol. 2002;61:396-402.
4. Limoli CL, Kaplan MI, Corcoran J, et al. Chromosomal instability and its relationship to other end points of genomic instability. Cancer Res. 1997;57:5557-5563.
5. Saxena A, Robertson JT, Ali IU. Abnormalities of p16, p15 and CDK4 genes in recurrent malignant astrocytomas. Oncogene. 1996;13:661-664.
6. Costanzi-Strauss E, Strauss BE, Naviaux RK, et al. Restoration of growth arrest by p16INK4, p21WAF1, pRB, and p53 is dependent on the integrity of the endogenous cell-cycle control pathways in human glioblastoma cell lines. Exp Cell Res. 1998;238:51-62.
7. Newcomb EW, Cohen H, Lee SR, et al. Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes. Brain Pathol. 1998;8:655-667.
8. Dams E, Van de Kelft EJZ, Martin JJ, et al. Instability of microsatellites in human gliomas. Cancer Res. 1995;55:1547-1549.
9. Zhu J, Guo SZ, Beggs AH et al. Microsatellite instability analysis of primary human brain tumors. Oncogenes. 1996;12:1417-1423.
10. Zhu JJ, Santarius T, Wu X, et al. Screening for loss of heterozygosity and microsatellite instability in oligodendrogliomas. Genes Chrom Cancer. 1998;21:207-216.
11. Dietmaier W, Wallinger S, Bocker T, et al. Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res. 1997;57:4749-4756.
12. Wei Q, Bondy ML, Mao L, et al. Reduced expression of mismatch repair genes measured by multiplex reverse transcription-polymerase chain reaction in human gliomas. Cancer Res. 1997;57:1673-1677.
13. Kanamori M, Kon H, Nobukuni T, et al. Microsatellite instability and the PTEN1 gene mutation in subset of early onset gliomas carrying germline mutation or promoter methylation of the hMLH1 gene. Oncogene. 2000;19:1564-1571.
14. Sobrido MJ, Pereira CR, Barros F, et al. Low frequency of replication errors in primary nervous system tumours. J Neurol Neurosurg Psychiat. 2000;69:369-375.
15. Yu J, Zhang H, Gu J, et al. Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma. BMC Cancer. 2004;4:65.
16. Dong SM, Pang JC, Poon W, et al. Concurrent hypermethylation of multiple genes is associated with grade of oligodendroglial tumors. J Neuropath Exp Neurol. 2001;60:808-816.
17. Gonzalez-Gomez P, Bello MJ, Arjona D, et al. Promoter hypermethylation of multiple genes in astrocytic gliomas. Int J Oncol. 2003;22:601-608.
18. Kleinhues P, Cavenee WK. WHO Classification of Tumours. Pathology and Genetics of Tumors of the Nervous System. Lyon: IARC Press; 2000.
19. Esteller M, Catasus L, Matias-Guiu X, et al. hMLH1 promoter hypermethylation is an early event in human endometrial tumorgenesis. Am J Pathol. 1999;155:1767-1772.
20. Herman JG, Umar A, Polyak K, et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci. 1998;95:6870-6875.
21. Fleisher AS, Esteller M, Tamura G, et al. Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasia. Oncogene. 2001;20:329-335.
22. Mollemann M, Wolter M, Felsberg J, et al. Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors. Int J Cancer. 2005;113:379-385.
23. Szyf M. DNA methylation and demethylation as targets for anticancer therapy. Biochemistry. 2005;70:651-669.
24. Friedman HS, Johnson SP, Dong Q, et al. Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multiforme xenograft. Cancer Res. 1997;57:4973.
25. Fukushima T, Katayama Y, Watanabe T, et al. Promoter hypermethylation of mismatch repair gene hMLH1 predict the clinical response of malignant astrocytoma to nitrosourea. Clin Cancer Res. 2005;11:1539-1544.